You are here

Medtech investor Clearbridge Health plans Catalist IPO

It expects operating expenses to go up in the near term after IPO, and can't be certain that it will achieve profitability


CLEARBRIDGE Health, the medtech investor formerly known as Clearbridge Accelerator, is planning an initial public offering (IPO) on the Singapore Exchange.

Clearbridge Health, which was renamed in April, lodged a draft prospectus for a listing on the Catalist board last

Market voices on:


Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at

Powered by GET.comGetCom